EPCAM and neoplasm: EpCAM is expressed in most but not all tumors [43]; there is downregulation with cancer progression and metastasis and cytokeratins are heterogeneously expressed in tumor cells and also may be downregulated during disease progression or in poorly differentiated tumors.